These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20424447)

  • 21. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
    Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
    Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
    Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of iloprost combined with low dose tadalafil in adult congenital heart disease patients with severe pulmonary arterial hypertension: a single-center, open-label controlled study].
    Zhang C; Huang Y; Huang T; Xia C; Huang X; Zhang G; Yao H; Chen J; Chen J; Wu S; Zhuang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):474-80. PubMed ID: 25164220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
    Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
    Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models related to congenital heart disease and clinical research in pulmonary hypertension.
    Loukanov T; Geiger R; Agrawal R
    Cardiology; 2010; 116(1):18-25. PubMed ID: 20424448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of inhaled nitric oxide and inhaled iloprost on hypoxaemia in a patient with pulmonary hypertension after pulmonary thrombarterectomy.
    Flondor M; Merkel M; Hofstetter C; Irlbeck M; Frey L; Zwissler B
    Anaesthesia; 2006 Dec; 61(12):1200-3. PubMed ID: 17090242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of inhaled aerosolized iloprost and inhaled NO on pulmonary circulation and edema formation in ovine lung injury.
    Hucklenbruch C; Hinder F; Berger C; Ertmer C; Lange M; Westphal M; Van Aken H; Ellger B; Dirk Stubbe H
    Shock; 2008 Jul; 30(1):75-80. PubMed ID: 18562927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease.
    Bizzarro M; Gross I; Barbosa FT
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD005055. PubMed ID: 24991723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhaled iloprost during acute pulmonary vasodilator testing for preoperative assessment of surgical operability of congenital heart disease with severe pulmonary hypertension].
    Gu H; Li QQ; Zhang C; Liu TY; Zhuo L; Liu HJ; Guo BJ; Hou J; Zhang H; Yi F; Luo Y
    Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):727-30. PubMed ID: 20646485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhaled nitric oxide: therapeutic applications in cardiac surgery].
    Estanove S; Girard C; Bastien O; Piriou V; Lehot JJ
    Bull Acad Natl Med; 2000; 184(8):1715-26; discussion 1727-9. PubMed ID: 11471390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.
    Scott JP; Higenbottam T; Wallwork J
    Br J Clin Pract; 1990 Jun; 44(6):231-4. PubMed ID: 1698429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L; Yang YH; Cui N; Xie WM; Zhai ZG; Ma ZH; Wang C
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2103-5. PubMed ID: 20058612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
    Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
    Rex S; Schaelte G; Metzelder S; Flier S; de Waal EE; Autschbach R; Rossaint R; Buhre W
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):65-72. PubMed ID: 17976224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.